Homosalate boosts the release of tumor-derived Extracellular Vesicles with anti-anoikis properties
E. Grisard, A. Lescure, N. Nevo, M. Corbe, M. Jouve, G. Lavieu, A. Joliot, E. Del Nery, l. martin jaular, C. Thery
The paper identifies Homosalate as a drug that increases EV release from triple negative breast cancer cells, which have anti-anoikis properties.
bioRxiv · Oct 25, 2021Cell Biology